Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • justarook04 justarook04 Mar 26, 2014 2:11 PM Flag

    Last july 1st we took a 20% hit

    It took us 45 days to recover and then we doubled in PPS within 6 months. Not that this makes today any better but the Analysts were right back then (even underestimated some) and I have to believe they have a clue. But as for today, yes, disappointed for awhile.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Last July the price was only able to stay at that level because the BOD released supplied several million shares priced at below $10.

      Who is now going to sell any serious amount of shares for anywhere near the current share price?

      With the Cystic Fibrosis results alone the shares were significantly undervalued at $20.

    • Why stay with a stock that has a pattern of disappointing investors? I took my lumps today at $16.00 after considering the forward risk of holding it, took a $2K loss. My initial entry was good too at 16.64, and had I not added at 19.37 I may have continued to hold it. Good luck, you are a committed long and will earn whatever profits you make.

      Sentiment: Sell

      • 1 Reply to jrdelane
      • JRdelane, These are tough times in the BIOs (NASDAQ is getting killed again today) and I wish I would have sold some INSM yesterday in the $19's. The key here is don't invest what you can not afford to (lose) based on timelines. There are many silver linings here that were never here before. Much better leadership for starters. A drug that is the ONLY one that has a chance to address NTM (and the disease continues to grow). We have continued support and belief by many Analysts (not just one). This drug has patents supporting it for many many years and Big Pharma may come calling. This is not a perfect drug. Listen to all the commercials that have most of their minutes with disclaimers (side effects) yet approved. CF treatment is looming with another 9 months of a 2 year study in place. AND today's read out was not all that bad or discouraging. Having said all this, the market acts first and asks questions later, so we suffer initially. It sucks but we will survive here to see this "puppy" through. Good luck to you!

        Sentiment: Buy

 
INSM
10.98-0.09(-0.81%)May 5 4:00 PMEDT